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Antibody against tumor-killing factor inhibited cytotoxic activities produced in vitro by mouse peritoneal 
macrophages and in vivo in the serum of tumor-bearing mice in response to Sarcophaga lectin. These results 
suggest hat tumor-killing factor participates in the antitumor effect of Sarcophaga lectin. 
(Sarcophaga, J774.1 cell) Lectin 
1. INTRODUCTION 
Sarcophaga lectin is a galactose-binding lectin 
purified from the hemolymph of Sarcophaga 
peregrina (flesh-fly) larvae [ 11. Although this lectin 
itself has no cytotoxic activity, it showed a marked 
antitumor effect when administered to tumor- 
bearing mice [2]. Conceivably macrophages ac- 
tivated by this lectin and cytokines produced by 
immune cells in response to this lectin cooperative- 
ly construct a systemic defence mechanism that is 
effective for regression of tumors. In fact, we have 
shown that Sarcophaga lectin activates 
macrophages and has significant cytotoxicity on 
both syngeneic and allogeneic murine tumor cells 
in the presence of macrophages [3,4]. We have also 
shown that cytotoxic activity transiently appears in 
the culture medium of murine peritoneal 
macrophages after addition of Sarcophaga lectin 
[2]. Furthermore, we have observed that cytotoxic 
activity transiently appears in the serum of tumor- 
bearing mice, but not normal mice, after injecting 
Sarcophaga lectin [2]. 
On the other hand, we have described the induc- 
tion of a tumor-specific cytotoxic protein by a 
murine macrophage-like cell line 5774.1 on treat- 
ment with Sarcophaga lectin, and the purification 
of this protein, termed tumor-killing factor (TKF), 
to homogeneity [5,6]. 
Tumor-killing factor Macrophage 
This paper demonstrates that antibody against 
TKF inhibits the cytotoxic activities produced in 
vitro and in vivo in response to the Sarcophaga lec- 
tin, suggesting that TKF is one of the major 
cytokines participating in the antitumor effect of 
Sarcophaga lectin. 
2. MATERIALS AND METHODS 
2.1. Sarcophaga lectin and TKF 
Sarcophaga lectin was purified as described 
before from the hemolymph of S. peregrina third 
instar larvae whose body wall had been pricked by 
a hypodermic needle 24 h previously [ 11. TKF was 
purified from the culture medium of 5774.1 cells 
treated with 5 pg/ml of Sarcophaga lectin for 48 h 
as described [6]. 
2.2. Antibody against TKF 
Purified TKF (75 pg) was thoroughly mixed with 
1 ml complete Freund’s adjuvant and injected sub- 
cutaneously into a male albino rabbit. A booster 
injection of 75 pg of TKF in incomplete Freund’s 
adjuvant was given two weeks later. The animal 
was bled one week after the booster injection, and 
the titer of the serum obtained was checked by im- 
munoprecipitation of radioiodinated TKF. 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/86/$3.50 0 1986 Federation of European Biochemical Societies 37 
Volume 201, number 1 FEBS LETTERS May 1986 
2.3. Cytotoxicity assay 
Cytotoxic activity in the sample was assayed 
essentially as described by Drysdale et al. [7], with 
L-929 cells as targets. After treatment of target 
cells with the sample containing cytotoxic activity, 
viable cells were stained with crystal violet, and the 
percentage cytotoxicity was calculated from the 
amount of dye adsorbed to the remaining cells. 
Neutralization of cytotoxic activity by antibody 
against TKF was determined by incubating the 
sample with antiserum for 6 h at 4°C and then 
measuring cytotoxic activity. 
after addition of the lectin, and then rapidly 
decreases. We examined the cytotoxic activity pro- 
duced by peritoneal macrophages by testing 
whether the antibody inhibited the activity in the 
culture medium of peritoneal macrophages. 
As shown in fig.1, the cytotoxic activity in the 
culture medium of macrophages was almost com- 
pletely inhibited by the antibody against TKF, 
whereas normal serum had no effect, suggesting 
that the cytotoxic activity produced by peritoneal 
macrophages in the presence of Sarcophaga lectin 
is due to the same protein as TKF. 
3.2. Inhibition of cytotoxic activity induced in the 
2.4. Sarcophaga lectin-dependent macrophage- serum of tumor-bearing mice 
mediated cytotoxic reaction 
The procedure used was as described [4]. 
Peritoneal macrophages of ICR mice and “Cr- 
labeled Ehrlich ascites tumor cells were incubated 
in the presence of 20gg/ml of Sarcophaga lectin 
for 17 h at 37”C, and then the 51Cr released from 
the target cells was measured. The effect of an- 
tibody against TKF on this reaction was examined 
by adding antiserum to the incubation mixture 
30 min before the target cells. 
3. RESULTS 
Since antibody against TKF is now available, we 
examined the effect of this antibody on various 
cytotoxic activities that are produced in vitro and 
in vivo in response to the stimulus of Sarcophaga 
lectin and are supposed to participate in the an- 
titumor effect of Sarcophaga lectin. 
Sarcophaga lectin itself has been shown to have 
a significant therapeutic effect when administered 
to tumor-bearing mice [2]. We demonstrated that 
when sarcoma 180 cells were inoculated into the 
abdominal cavity 24 h before intraperitoneal injec- 
tion of Sarcophaga lectin, significant cytotoxic ac- 
tivity transiently appeared in the serum 1.5 h after 
injection of Sarcophaga lectin, but that this activi- 
ty was not detectable in the serum of control 
animals after injection of Sarcophaga lectin [2]. 
This activity was found to be inhibited by the an- 
tibody against TKF, as shown in fig.2. Thus, it is 
clear that TKF is transiently induced in the serum 
of tumor-bearing mice soon after the injection of 
Sarcophaga lectin. 
3.1. Inhibition of cytotoxic activity produced by 
peritoneal macrophages 
As reported before, we found that mouse 
peritoneal macrophages produce cytotoxic activity 
when they are cultured in the presence of Sar- 
cophaga lectin [2]. However, the patterns of pro- 
duction of cytotoxic activity by peritoneal 
macrophages and 5774.1 cells are different. Name- 
ly, when 5774.1 cells are stimulated by Sarcophaga 
lectin, the cytotoxic activity in the medium in- 
creases linearly for at least 72 h, whereas when 
peritoneal macrophages are stimulated, the 
cytotoxic activity increases to a maximum 1.5 h 
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Fig. 1. Inhibition by antibody against TKF of cytotoxic 
activity in the culture medium of peritoneal 
macrophages. Increasing amounts of antiserum were 
added to the culture medium of peritoneal macrophages 
containing 3.1 units of cytotoxic activity, and the 
remaining activity was assayed with L-929 cells as 
targets. Lanes: 1, control (without serum); 2, normal 
serum (3.2 ~1); 3-7,0.4,0.8, 1.6,3.2 and 6 ~1 antiserum, 
respectively. 
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Fig.2. Inhibition by antibody against TKF of cytotoxic 
activity induced in the serum of tumor-bearing mice. 
Increasing amounts of antiserum were added to the 
serum of tumor-bearing mice treated with Surcophagu 
lectin. The original cytotoxic activity of the serum was 
14.2 units. Lanes: 1, control (without serum); 2, normal 
serum (3.2 ~1); 3-7,0.4,0.8, 1.6,3.2 and 6 /cl antiserum, 
respectively. 
3.3. Participation of TKF in the Sarcophaga 
lectin-dependent macrophage-mediated 
cytotoxic reaction 
We have shown that Sarcophaga lectin exhibits 
macrophage-dependent cytotoxicity to both 
syngeneic and allogeneic tumors [3,4]. Namely, 
when either syngeneic MM46 tumor cells and 
C3H/He mouse macrophages, or Ehrlich ascites 
tumor cells and ICR mouse macrophages were in- 
cubated in the presence of Sarcophaga lectin, the 
target cells were lysed with time. 
We tested the effect of antibody against TKF on 
the lysis of Ehrlich ascites tumor cells in this reac- 
tion. As shown in fig.3, antibody against TKF 
significantly and dose-dependently inhibited the 
lysis of Ehrlich ascites tumor cells, whereas normal 
serum had no effect on their lysis. Thus we con- 
clude that TKF produced by peritoneal 
macrophages in culture in the presence of Sar- 
cophaga lectin mainly participates in the lysis of 
target cells. 
4. DISCUSSION 
From the results obtained with antibody against 
TKF, we conclude that the cytotoxic activities 
detected in vitro and in vivo when peritoneal 
macrophages or tumor-bearing mice are treated 
with Sarcophaga lectin are due to immunologically 
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Fig.3. Effect of antibody against TKF on the 
Sarcophuga lectin-dependent macrophage-mediated 
cytotoxic reaction. Macrophages (“Cr-labeled Ehrlich 
ascites tumor cells), Surcophuga lectin, and various 
amounts of antiserum were incubated at 37°C for 17 h 
in RPM1 1640 medium, and then cytolysis of the tumor 
cells was measured. (0) Control serum, (0) antiserum. 
the same protein as TKF, which is a cytotoxic pro- 
tein produced by 5774.1 cells in response to Sar- 
cophaga lectin. Therefore, one of the major 
cytokines participating in the antitumor effect of 
Sarcophaga lectin is TKF. Since TKF has a similar 
amino acid composition to that of tumor-necrosis 
factor (TNF-~Y), TKF may be TNFY.Y itself or a 
related protein. 
Since Sarcophaga lectin alone is sufficient to in- 
duce TKF, it may be important to investigate how 
the stimulus from this lectin is transmitted to the 
macrophage nucleus to activate the TKF gene 
selectively. Recently, we identified three proteins 
with affinities to Sarcophaga lectin in the 
macrophage membrane; these proteins have 
molecular masses of 170, 110 and 55 kDa, respec- 
tively 141. Probably, some signal that is essential 
for subsequent activation of the TKF gene is 
created in situ when Sarcophaga lectin binds to one 
of these proteins. As this is a relatively simple 
system, it may be possible to use it to analyze the 
mechanism of selective activation of the TKF gene 
by Sarcophaga lectin. 
We demonstrated that most of the Sarcophaga 
lectin-dependent macrophage-mediated cytotoxici- 
ty is due to TKF. However, there also seems to be 
another unknown cytotoxic mechanism, since 
about 20% of the cytotoxicity was not inhibited by 
the antibody against TKF even at higher doses, as 
shown in fig.3. 
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